My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

19.63 +0.46 (+2.40%)
Streaming Delayed Price Updated: 10:52 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,367
Open 19.05
Bid (Size) 19.50 (1)
Ask (Size) 19.63 (2)
Prev. Close 19.17
Today's Range 18.82 - 19.64
52wk Range 7.080 - 20.43
Shares Outstanding 407,265,944
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
From Amarin Corporation plc
Via GlobeNewswire
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action -- 
From Amarin Corporation plc
Via GlobeNewswire

Performance

YTD
+87.5%
+87.5%
1 Month
+31.5%
+31.5%
3 Month
+21.9%
+21.9%
6 Month
+107.3%
+107.3%
1 Year
+68.6%
+68.6%

More News

Read More
New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
From Amarin Corporation plc
Via GlobeNewswire
Earnings Scheduled For July 30, 2025
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Exploring Amarin Corp's Earnings Expectations
Via Benzinga
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
From Amarin Corporation plc
Via GlobeNewswire
Amarin Reports Second Quarter 2025 Financial Results
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025
From Amarin Corporation plc
Via GlobeNewswire
Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA
Via Benzinga
Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are gapping on Tuesday?
Via Chartmill
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
From Amarin Corporation plc
Via GlobeNewswire
Amarin Reports First Quarter 2025 Financial Results
From Amarin Corporation plc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Amarin Corporation plc
Via GlobeNewswire
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
From Amarin Corporation plc
Via GlobeNewswire
Top 2 Health Care Stocks That May Crash This Month
Via Benzinga
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
Via Benzinga
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Via Benzinga
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
From Amarin Corporation plc
Via GlobeNewswire
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
From Amarin Corporation plc
Via GlobeNewswire
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
From Amarin Corporation plc
Via GlobeNewswire
New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of
From Amarin Corporation plc
Via GlobeNewswire

Frequently Asked Questions

Is Amarin Corporation plc - American Depositary Shares publicly traded?
Yes, Amarin Corporation plc - American Depositary Shares is publicly traded.
What exchange does Amarin Corporation plc - American Depositary Shares trade on?
Amarin Corporation plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Amarin Corporation plc - American Depositary Shares?
The ticker symbol for Amarin Corporation plc - American Depositary Shares is AMRN on the Nasdaq Stock Market
What is the current price of Amarin Corporation plc - American Depositary Shares?
The current price of Amarin Corporation plc - American Depositary Shares is 19.63
When was Amarin Corporation plc - American Depositary Shares last traded?
The last trade of Amarin Corporation plc - American Depositary Shares was at 10/14/25 10:52 AM ET
What is the market capitalization of Amarin Corporation plc - American Depositary Shares?
The market capitalization of Amarin Corporation plc - American Depositary Shares is 7.99B
How many shares of Amarin Corporation plc - American Depositary Shares are outstanding?
Amarin Corporation plc - American Depositary Shares has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.